You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
A research trio traces the origin of genital herpes in humans to Paranthropus boisei, according to LiveScience.
The Aptima HSV 1 & 2 nucleic acid amplification test qualitatively detects and differentiates between HSV-1 and HSV-2 on the automated Panther system.
In PLOS this week: regulators of brown adipocyte differentiation, longevity and FOXO3 variants, and more.
The test is the fifth assay on the Solana platform to obtain clearance, and expands the firm's offerings in the women's health market.
The Public Health England lab plans to continue to use Oxford Nanopore's MinIon to help discover novel resistance mutations and elements that influence virulence.
Researchers use the CRISPR/Cas9 gene editing approach to limit herpesviruses replication.
The multiplex qPCR test can detect and discriminate herpes simplex virus 1 and 2 as well as varicella zoster virus, which can be mistaken for HSV in a proportion of cases.
The company issued the Class I recall in February because poor lamination between sample reaction wells led to inaccurate results, but has since resolved the issue.
The platform and the assay were cleared by the US Food and Drug Administration in October and were launched in the US shortly thereafter.
In PNAS this week: single-stranded cytosine deamination in E. coli, characterization of herpes simplex virus-1 microRNAs, and more.
Undark looks into how coronavirus-related shutdowns are affecting field researchers.
In PNAS this week: strategies to design DNA oligonucleotide probes for bacteria, Vibrio cholerae evolution in Haiti, and more.
NPR reports that graduate students in the US are helping with SARS-CoV-2 testing.
Politico reports President Donald Trump has signed the $2 trillion coronavirus relief package.